Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice

American Journal of Pathology

Volumn 153, Issue 2, 1998, Pages 639-648

  Schirmacher, Peter ^a   Peters, Malte ^a   Ciliberto, Gennaro ^b   Blessing, Manfred ^a,c   Lotz, Johannes ^a   Meyer Zum Büschenfelde, Karl Hermann ^a   Rose John, Stefan ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b IRBM   (Italy)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EXTRAMEDULLARY HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; LIGAND BINDING; LIVER HYPERPLASIA; LIVER NECROSIS; MITOGENESIS; NONHUMAN; PELIOSIS HEPATIS; PHENOTYPE; PLASMACYTOMA; PRIORITY JOURNAL; SPLEEN; TRANSGENIC MOUSE;

EID: 0031858640     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65605-2     Document Type: Article

References (32)

1. Akira S, Taga T, Kishimoto T: Interleukin-6 in biology and medicine. Adv Immunol 1993, 54:1-78
2. Bauer J, Herrmann F: Interleukin-6 in clinical medicine. Ann Hematol 1991, 62:203-210
3. Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H: Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 1987, 84:7251-7255
4. Grötzinger J, Kurapkat G, Wollmer A, Kalai M, Rose-John S: The family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexes. Proteins Struct Funct Genet 1997, 27:96-109
5. Hibi M, Nakajima K, Hirano T: IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med 1996, 74:1-12
6. Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, Nakajima K, Hirano T: Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 1996, 5:449-460
7. Schindler C, Darnell JE: Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 1995, 64:621-651
8. Rose-John S, Heinrich PC: Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 1994, 300:281-290
9. Müllberg J, Dittrich E, Graeve L, Gerhartz C, Yasukawa K, Taga T, Kishimoto T, Heinrich PC, Rose-John S: Differential shedding of the two subunits of the interleukin-6 receptor. FEBS Lett 1993, 332:174-178
10. Müllberg J, Durie FH, Otten Evans C, Alderson MR, Rose-John S, Cosman D, Black RA, Mohler KM: A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J Immunol 1995, 155:5198-5205
11. Müllberg J, Schooltink H, Stoyan T, Gunther M, Graeve L, Buse G, Mackiewicz A, Heinrich PC, Rose-John S: The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 1993, 23:473-480
12. Peters M, Jacobs S, Ehlers M, Vollmer P, Müllberg J, Wolf E, Brem G, Meyer zum Büschenfelde KH, Rose-John S: The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J Exp Med 1996, 183:1399-1406
13. März P, Herget T, Lang E, Otten U, Rose-John S: Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation. Eur J Neurosci 1997, 9:2765-2773
14. Sui X, Tsuji K, Tanaka R, Tajima S, Muraoka K, Ebihara Y, Ikebuchi K, Yasukawa K, Taga T, Kishimoto T, Nagahata T: gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. Proc Natl Acad Sci USA 1995, 92:2859-2863
15. DeBenedetti F, Massa M, Pignatti P, Albani S, Novick D, Martini A: Serum soluble interleukin-6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest 1994, 93:2114-2119
16. Suematsu S, Matsuda T, Aozasa K, Akira S, Nakano N, Ohno S, Miyazaki J, Yamamura K, Hirano T, Kishimoto T: IgG1 plasmacytosis in interleukin 6 transgenic mice Proc Natl Acad Sci USA 1989, 86:7547-7551
17. Suematsu S, Matsusaka T, Matsuda T, Ohno S, Miyazaki J-I, Yamamura K-I, Hirano T, Kishimoto T: Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 1992, 89:232-235
18. van Dam M, Müllberg J, Schooltink H, Stoyan T, Brakenhoff JP, Graeve L, Heinrich PC, Rose-John S: Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules: involvement of two separate domains in receptor binding. J Biol Chem 1993, 268:15285-15290
19. Fattori E, Della Rocca C, Costa P, Giorgio M, Dente B, Pozzi L, Ciliberto G: Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. Blood 1994, 83:2570-2579
20. Bartels H, Herbort H, Jungermann K: Predominant periportal expression of the phosphoenolpyrovate carboxykinase and tyrosine aminotransferase genes in rat liver. Histochemistry 1990, 99:303-309
21. McGrane MM, deVente J, Yun J, Bloom J, Park E, Wynshaw-Boris A, Wagner T, Rottman RM, Hanson RW: Tissue-specific expression and dietary regulation of a chimeric phosphoenolpyruvate carboxykinase/ bovine growth hormone gene in transgenic mice. J Biol Chem 1988, 263: 11443-11451
22. Peters M, Schirmacher P, Goldschmitt J, Odenthal M, Peschel C, Dienes HP, Fattori E, Ciliberto G, Meyer zum Büschenfelde KH, Rose-John S: Extramedullary expansion of hematopoietic progenitor cells in IL-6/SIL-6R double transgenic mice. J Exp Med 1997, 185: 755-766
23. Tajima S, Tsuji K, Ebihara Y, Sui X, Tanaka R, Muraoka K, Yoshida M, Yamada K, Yasukawa K, Taga T, Kishimoto T, Nakahata T: Analysis of interleukin-6 receptor and gp130 expressions and proliferative capability of human CD34+ cells. J Exp Med 1996, 184:1357-1364
24. Kallen K-J, Meyer zum Büschenfelde K-H, Rose-John S: The therapeutic potential of interleukin-6 hyperagonists and antagonists. Exp Opin Invest Drugs 1997, 6:237-266
25. Kyrtsonis MC, Dedoussis G, Zervas C, Perifanis V, Baxevanis C, Stamatelou M, Maniatis A: Soluble interleukin-6 receptor (SIL-6R), a new prognostic factor in multiple myeloma. Br J Haematol 1996, 93:398-400
26. Papadaki H, Kyriakou D, Foudoulakis A, Markidou F, Alexandrakis M, Eliopoulos GD: Serum levels of soluble IL-6 receptor in multiple myeloma as indicator of disease activity. Acta Haematol 1997, 97: 191-195
27. Pulkki K, Pelliniemi TT, Rajamaki A, Tienhaara A, Laakso M, Lahtinen R: Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma: Finnish leukaemia group. Br J Haematol 1996, 92:370-374
28. Peters M, Odenthal M, Schirmacher P, Blessing M, Ciliberto G, Meyer zum Büschenfelde KH, Rose-John S: Soluble IL-6 receptor leads to a paracrine modulation of the hepatic acute phase response in double transgenic mice. J Immunol 1997, 159:1474-1481
29. Lavabre Bertrand T, Exbrayat C, Liautard J, Gaillard JP, Baskevitch PP, Poujol N, Duperray C, Bourquard P, Brochier J: Detection of membrane and soluble interleukin-6 receptor in lymphoid malignancies. Br J Haematol 1995, 91:871-877
30. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R: Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996, 274:1379-1383
31. Trautwein C, Rakemann T, Niehof M, Rose-John S, Manns MP: Acute-phase response factor, increased binding, and target gene transcription during liver regeneration. Gastroenterology 1996, 110:1854-1862
32. Yamada Y, Kirillova I, Peschon JJ, Fausto N: Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 1997, 94:1441-1445